ES2072983T3 - Metodo para evaluar la sensibilidad de vih-1 a la zidovudina y oligonucleotidos para el mismo. - Google Patents

Metodo para evaluar la sensibilidad de vih-1 a la zidovudina y oligonucleotidos para el mismo.

Info

Publication number
ES2072983T3
ES2072983T3 ES90308721T ES90308721T ES2072983T3 ES 2072983 T3 ES2072983 T3 ES 2072983T3 ES 90308721 T ES90308721 T ES 90308721T ES 90308721 T ES90308721 T ES 90308721T ES 2072983 T3 ES2072983 T3 ES 2072983T3
Authority
ES
Spain
Prior art keywords
zidovudine
hiv
assess
sensitivity
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90308721T
Other languages
English (en)
Inventor
Brendan Alexander Larder
Sharon Dawn Symons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10661415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2072983(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2072983T3 publication Critical patent/ES2072983T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTE INVENTO RELATA UNA METODOLOGIA PARA VALORAR LA SENSIBILIDAD DE UNA MUESTRA HIV-1 AL ZIDOVUDINE Y PARA DIAGNOSTICAR ENSAYOS PARA USO EN TALES VALORACIONES.
ES90308721T 1989-08-09 1990-08-08 Metodo para evaluar la sensibilidad de vih-1 a la zidovudina y oligonucleotidos para el mismo. Expired - Lifetime ES2072983T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918226A GB8918226D0 (en) 1989-08-09 1989-08-09 Dna assays

Publications (1)

Publication Number Publication Date
ES2072983T3 true ES2072983T3 (es) 1995-08-01

Family

ID=10661415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90308721T Expired - Lifetime ES2072983T3 (es) 1989-08-09 1990-08-08 Metodo para evaluar la sensibilidad de vih-1 a la zidovudina y oligonucleotidos para el mismo.

Country Status (12)

Country Link
US (2) US5409810A (es)
EP (1) EP0422762B1 (es)
JP (1) JP3105907B2 (es)
AU (1) AU638475B2 (es)
CA (1) CA2022942C (es)
DE (1) DE69019795T2 (es)
DK (1) DK0422762T3 (es)
ES (1) ES2072983T3 (es)
GB (1) GB8918226D0 (es)
IE (1) IE69846B1 (es)
NZ (1) NZ234812A (es)
ZA (1) ZA906263B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39282E1 (en) * 1989-08-09 2006-09-12 Smithkline Beecham Corporation Nucleic acid derivatives
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
AU1741692A (en) * 1991-03-13 1992-10-21 Regents Of The University Of California, The Detection of 3'-azido-3'-deoxythymidine resistance
DE4129653A1 (de) * 1991-09-06 1993-03-11 Boehringer Mannheim Gmbh Verfahren zum nachweis aehnlicher nukleinsaeuren
AU4248593A (en) 1992-05-14 1993-12-13 Mark Holodniy Polymerase chain reaction assays for monitoring antiviral therapy
US5827648A (en) * 1995-12-13 1998-10-27 Chiron Corporation Differential hybridization for relative quantification of variant populations
AU694205B2 (en) * 1994-04-19 1998-07-16 Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus
US6265152B1 (en) 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US6007983A (en) * 1995-12-22 1999-12-28 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
AU719691B2 (en) 1996-01-26 2000-05-18 Innogenetics N.V. Method for detection of drug-induced mutations in the reverse transcriptase gene
US20030033617A1 (en) * 1996-04-10 2003-02-13 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US20020160970A1 (en) * 1996-04-10 2002-10-31 Gyula Hadlaczky Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6077697A (en) 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
BR9911457A (pt) 1998-06-24 2001-12-11 Univ Emory Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
EP1185712B8 (en) 1999-05-28 2005-10-19 Virco Bvba New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP2020450B9 (en) * 2000-09-01 2011-09-14 Gen-Probe Incorporated Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations
ES2399806T3 (es) * 2000-09-28 2013-04-03 Bioriginal Food & Science Corp. Miembro de la familia de desaturasa de ácido graso fad6 y usos del mismo
AU2631602A (en) 2000-10-20 2002-04-29 Virco Nv New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
WO2004003817A1 (en) 2002-07-01 2004-01-08 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
ATE397669T1 (de) 2002-07-01 2008-06-15 Tibotec Pharm Ltd Mit phänotypischer medikamentenresistenz korrelierte mutationsprofile in hiv-1-reverse- transkriptase
US6834479B2 (en) * 2002-10-03 2004-12-28 Src Innovations, Llc Bagging machine having a collapsible tunnel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization

Also Published As

Publication number Publication date
CA2022942C (en) 1999-12-21
GB8918226D0 (en) 1989-09-20
EP0422762A3 (en) 1992-08-05
EP0422762B1 (en) 1995-05-31
IE902860A1 (en) 1991-02-27
DE69019795T2 (de) 1995-11-02
JP3105907B2 (ja) 2000-11-06
USRE37918E1 (en) 2002-12-03
AU638475B2 (en) 1993-07-01
EP0422762A2 (en) 1991-04-17
CA2022942A1 (en) 1991-02-10
NZ234812A (en) 1991-09-25
ZA906263B (en) 1992-04-29
US5409810A (en) 1995-04-25
JPH03133400A (ja) 1991-06-06
IE69846B1 (en) 1996-10-02
AU6082890A (en) 1991-02-14
DK0422762T3 (da) 1995-07-24
DE69019795D1 (de) 1995-07-06

Similar Documents

Publication Publication Date Title
ES2072983T3 (es) Metodo para evaluar la sensibilidad de vih-1 a la zidovudina y oligonucleotidos para el mismo.
BR8302286A (pt) Aperfeicoamento em processo para determinacao da presenca de um analisador em uma amostra, aparelho de diagnostico inteiramente calibrado e kit para uso em um ensaio diagnostico
ES2160714T3 (es) Analisis y dispositivos para la deteccion de atresia biliar extrahepatica.
ES2116578T3 (es) Procedimiento y dispositivo para evaluar la aptitud de biopolimeros.
DE69429481D1 (de) Anzeigevorrichtung für die Ergebnisse von klinischen Tests
BR7503071A (pt) Cartao de teste de diagnostico e processo para determinacao de funcao ou estado de um orgao pelo emprego do dito cartao de teste
DE69010785D1 (de) System zum Messen von durch ein Endoskop beobachteten Gegenständen.
DE3689490D1 (de) Elektronenstrahlprüfsonde zur Untersuchung integrierter Schaltungen.
BR9708421A (pt) Processo para a deteccão de doenca provocada por prions teste diagnostico ou kit de teste e uso do processo
IT8521902A0 (it) Procedimento e dispositivo per la misurazione degli spessori sui pezzi in prova mediante ultrasuoni.
DK0782706T3 (da) Testmetode
MX9706437A (es) Proceso y compuestos para la deteccion de analitos usando medicion de remanencia y el uso de los mismos.
DE59006427D1 (de) Mehrkomponenten-Kraftmessanordnung ohne Messplatte.
IT1100970B (it) Apaprecchiatura di prova o collaudo ultrasonico
DE58909813D1 (de) Vorrichtung für die zerstörungsfreie Werkstoffprüfung
BR9407504A (pt) Dispositivo de teste para ensaio kit para realizar um ensaio e processo para determinar a presença de um anólito em um individuo em teste
ES2187674T3 (es) Procedimiento de deteccion del cancer.
ES2149505T3 (es) Mejoras en o relacionadas con un aparato de ensayo de construcciones.
BR7406779D0 (pt) Preparacao antigena processo e cartao de teste para realizacao de um teste de aglutinacao para sifilis e outras doencas causadas por treponema
Jones et al. Comparison of R-resistance curves(fracture strength)
Brinson et al. Test specimen geometries for evaluating adhesive durability
IT7868394A0 (it) Apparecchio per la valutazione qualitativa di prove di stampa e simili
KR970046795U (ko) 웨이퍼 테스트용 양면 프로브카드
UA9571A (uk) Спосіб електропунктурної діагностики "дін" та пристрій для його здійснення
DE59401353D1 (de) Prüfeinrichtung zur zerstörungsfreien werkstoffprüfung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 422762

Country of ref document: ES